Back to Results
First PageMeta Content
Doctoral degrees / Doctor of Medicine / Higher education / Minimal residual disease / Education / Academia / Knowledge


Minimal Residual Disease (MRD) as a Surrogate Endpoint in Chronic Lymphocytic Leukemia (CLL) Workshop R. Angelo de Claro, M.D., William Wierda, M.D., Ph.D., and Gregory Reaman, M.D., Co-Chairs
Add to Reading List

Open Document

File Size: 35,10 KB

Share Result on Facebook

City

Dinndorf / /

MedicalCondition

Minimal Residual Disease / /

Organization

U.S. Food and Drug Administration American Society of Clinical Oncology / FDA / Leukemia and Lymphoma Society American Society of Hematology / /

Person

Edvardas Kaminskas / Emili Montserrat / Gregory Reaman / R. Angelo de Claro / William Wierda / Andy Rawstron / Gerald Marti / Paola Ghia / Maryalice Stetler Stevenson / Elizabeth Mansfield / John Byrd / Mark Rothmann / Albert Deisseroth / Peter Hillmen / /

SocialTag